NORTH CHICAGO, Ill. , May 20, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial officer, and

NORTH CHICAGO, Ill. , May 12, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial officer,

- Reports First-Quarter Diluted EPS of $1.99 on a GAAP Basis; Adjusted Diluted EPS of $2.95 - Delivers First-Quarter Net Revenues of $13.010 Billion on a GAAP Basis, an Increase of 51.0 Percent on a Reported Basis; Adjusted Net Revenues Were $12.935 Billion - First-Quarter Global Net Revenues from

NORTH CHICAGO, Ill. , March 31, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2021 financial results on Friday, April 30, 2021 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .

NORTH CHICAGO, Ill. , Feb. 19, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Cowen 41 st Annual Health Care Conference on Wednesday, March 3, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial officer, and

NORTH CHICAGO, Ill. , Feb. 18, 2021 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share.  The cash dividend is payable May 14, 2021 to stockholders of record at the close of business on April 15, 2021 .

NORTH CHICAGO, Ill. , Feb. 12, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 10 th Annual SVB Leerink Global Healthcare Conference on Friday, February 26 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial

- Reports Full-Year Diluted EPS of $2.72 on a GAAP Basis; Adjusted Diluted EPS of $10.56 - Delivers Full-Year Net Revenues of $45.804 Billion on a GAAP Basis, an Increase of 37.7 Percent on a Reported Basis; Adjusted Net Revenues Were $45.784 Billion - Full-Year Global Net Revenues from the

NORTH CHICAGO, Ill. , Jan. 12, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2020 financial results on Wednesday, February 3, 2021 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .

NORTH CHICAGO, Ill. , Jan. 6, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 39 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 . Members of AbbVie's executive leadership team will present virtually at 3:30 p.m. Central time , including Richard A.